Chris Markoch

Chris Markoch

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

Is It Time to End the Debate About Workhorse Stock?

Electric vehicles are no longer a political punching bag, and that's good news for the long-term fortunes of WKHS stock.

Buying AT&T Stock Is a Question of When, Not If

Unlike other 5G names, AT&T stock has not treated growth investors well. But the company has time to clean up its balance sheet.

3 Airline Stocks That Are Set to Soar

Times are anything but normal for airlines. But the possibility of a vaccine has analysts issuing new opinions on airline stocks to buy.

Is Kensington Capital Stock a Better Mousetrap or Just a Trap?

Kensington Capital is bringing QuantumScape public through a reverse merger. The question is if Kensington Capital stock is betting on a better mousetrap.

Why You Shouldn’t Trade Nio On Tesla News

Nio stock has surged as liquidity fears have gone away. But when looking at the future, don't be fooled by news its competition makes.

Buying Occidental Petroleum May Be Easy Money, But It’s Not Smart Money

Occidental's risky acquisition of Anadarko Petroleum continues to weigh on the company's balance sheet. That's reason enough to avoid OXY stock.

It’s Time To Look at Nikola With Fresh Eyes

Shrouded in controversy, Nikola stock is giving investors a chance to look at the company with fresh eyes. If they believe in hydrogen, they may like what they see.

3 Reasons Why Amazon Is Still a Buy

The recent dip in AMZN stock is part of a broader selloff in big tech. Some analysts think the stock will fall further. But in the short term, it appears to be smooth sailing.

Why Moderna May Be Ready to Deliver an October Surprise

MRNA stock is up 25% since early September on renewed hope the company gets its Covid-19 vaccine through clinical trials by November.

DiamondPeak Stock May Be the Right Stock at the Wrong Time

DiamondPeak stock is the latest EV stock to catch investors' fancy. But there is a lot of uncertainty to deal with before products arrive in late 2021.